WisdomTree BioRevolution Fund
WDNA
7 hedge funds and large institutions have $2.35M invested in WisdomTree BioRevolution Fund in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, reducing their positions, and 0 closing their positions.
52.24% more ownership
Funds ownership: 226.76% → 279.01% (+52%)
19% more capital invested
Capital invested by funds: $1.97M → $2.35M (+$380K)
17% more funds holding
Funds holding: 6 → 7 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$297K |
| 2 |
Jane Street
New York
|
+$121K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$56K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.78K |
Top Sellers
WDNA Hedge Fund Activity: Q3 2022 in Review
7 institutional investors reported a position in WisdomTree BioRevolution Fund (WDNA) for Q3 2022, worth a combined $2.35M — up 19% from $1.97M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new WDNA positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Flow Traders U.S., adding an estimated $297K.
- 7 institutional investors held WisdomTree BioRevolution Fund (WDNA) as of Q3 2022, up from 6 in Q2 2022.
- Funds reported $2.35M of WisdomTree BioRevolution Fund stock for Q3 2022, up 19% quarter-over-quarter.
- 1 fund opened new WisdomTree BioRevolution Fund positions in Q3 2022 and 0 closed out, a net change of +1 holder.
- The largest WisdomTree BioRevolution Fund buyer in Q3 2022 was Flow Traders U.S., an estimated $297K added.
Based on aggregated 13F filings for Q3 2022.